Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alirocumab in Heart Transplantation
NCT03537742Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2019
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
A Phase 2 trial of alirocumab in cardiac allograft vasculopathy (CAV), sponsored by Stanford University. Started May 2019; status: completed.
02
Drugs
alirocumab
03
Conditions
cardiac allograft vasculopathy (CAV)
Beyond the preview
Go deeper on NCT03537742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537742.